Nevro Capital Surpluse from 2010 to 2025

NVRO Stock  USD 5.79  0.02  0.35%   
Nevro Corp Capital Surpluse yearly trend continues to be very stable with very little volatility. Capital Surpluse is likely to drop to about 686.8 M. During the period from 2010 to 2025, Nevro Corp Capital Surpluse quarterly data regression pattern had sample variance of 77915.7 T and median of  552,612,000. View All Fundamentals
 
Capital Surpluse  
First Reported
2014-09-30
Previous Quarter
934.1 M
Current Value
945.4 M
Quarterly Volatility
234.9 M
 
Yuan Drop
 
Covid
Check Nevro Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nevro Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 14.8 M, Interest Expense of 28.2 M or Selling General Administrative of 225 M, as well as many indicators such as Price To Sales Ratio of 0.32, Dividend Yield of 0.0 or PTB Ratio of 0.57. Nevro financial statements analysis is a perfect complement when working with Nevro Corp Valuation or Volatility modules.
  
Check out the analysis of Nevro Corp Correlation against competitors.
To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.

Latest Nevro Corp's Capital Surpluse Growth Pattern

Below is the plot of the Capital Surpluse of Nevro Corp over the last few years. It is Nevro Corp's Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nevro Corp's overall financial position and show how it may be relating to other accounts over time.
Capital Surpluse10 Years Trend
Slightly volatile
   Capital Surpluse   
       Timeline  

Nevro Capital Surpluse Regression Statistics

Arithmetic Mean593,129,912
Geometric Mean531,514,437
Coefficient Of Variation47.06
Mean Deviation239,073,527
Median552,612,000
Standard Deviation279,133,895
Sample Variance77915.7T
Range780.3M
R-Value0.90
Mean Square Error15136.9T
R-Squared0.82
Slope53,048,811
Total Sum of Squares1168736T

Nevro Capital Surpluse History

2025686.8 M
20241.1 B
2022934.1 M
2021928.1 M
2020880.7 M
2019626.4 M
2018552.6 M

About Nevro Corp Financial Statements

Nevro Corp investors utilize fundamental indicators, such as Capital Surpluse, to predict how Nevro Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Capital Surpluse1.1 B686.8 M
When determining whether Nevro Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nevro Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nevro Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nevro Corp Stock:
Check out the analysis of Nevro Corp Correlation against competitors.
To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.06)
Revenue Per Share
11.015
Quarterly Revenue Growth
(0.09)
Return On Assets
(0.1)
Return On Equity
(0.43)
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.